This site uses cookies to improve your experience. If you continue without changing your settings, we’ll assume you’re happy to receive all cookies on this site. Our privacy policy can be found here.



Jan. 14, 2019

The U.S. Food and Drug Administration (FDA) approved the world's first medical device that can be implanted in the tiniest babies (weighing as little as 700g) using a minimally invasive procedure to treat patent ductus arteriosus, or PDA. The occluder is even smaller than a small pea, creating hope for premature infants and newborns who need corrective treatment, and who may be non-responsive to medical management and a high risk to undergo corrective surgery.

This device is able to occlude a variety of duct sizes, or elongated ducts.

You are about to leave

You are now leaving Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.